Total Payments
$3,134
2024 Payments
$507.70
Companies
35
Transactions
134
Medicare Patients
6,796
Medicare Billing
$519,640
Payment Breakdown by Category
Food & Beverage$2,707 (86.4%)
Travel$299.16 (9.5%)
Education$127.89 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,707 | 126 | 86.4% |
| Travel and Lodging | $299.16 | 4 | 9.5% |
| Education | $127.89 | 4 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $417.06 | 16 | $0 (2023) |
| Amgen Inc. | $341.14 | 19 | $0 (2024) |
| Spinal Simplicity, LLC | $299.16 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $219.58 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $199.32 | 13 | $0 (2022) |
| Boston Scientific Corporation | $187.85 | 7 | $0 (2020) |
| NxStage Medical, Inc. | $135.18 | 1 | $0 (2023) |
| MML US, Inc. | $126.79 | 1 | $0 (2024) |
| Mallinckrodt LLC | $108.99 | 3 | $0 (2018) |
| Keryx Biopharmaceuticals, Inc. | $102.20 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $507.70 | 10 | Spinal Simplicity, LLC ($299.16) |
| 2023 | $200.77 | 5 | NxStage Medical, Inc. ($135.18) |
| 2022 | $204.90 | 12 | Vifor Pharma, Inc. ($33.54) |
| 2021 | $302.41 | 13 | AstraZeneca Pharmaceuticals LP ($160.29) |
| 2020 | $323.47 | 22 | Merck Sharp & Dohme Corporation ($45.17) |
| 2019 | $429.43 | 23 | Amgen Inc. ($127.21) |
| 2018 | $812.70 | 30 | OPKO Pharmaceuticals, LLC ($267.11) |
| 2017 | $352.49 | 19 | Astute Medical, Inc. ($80.80) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Rare Disease | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $126.79 | General |
| Category: Pain Management | ||||||
| 07/12/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Travel and Lodging | In-kind items and services | $262.00 | General |
| Category: SPINAL HARDWARE | ||||||
| 06/24/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Travel and Lodging | In-kind items and services | $16.72 | General |
| Category: SPINAL HARDWARE | ||||||
| 06/24/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Travel and Lodging | In-kind items and services | $16.72 | General |
| Category: SPINAL HARDWARE | ||||||
| 06/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Rare Disease | ||||||
| 05/17/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Travel and Lodging | Cash or cash equivalent | $3.72 | General |
| Category: SPINAL HARDWARE | ||||||
| 01/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Inflammation | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2023 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $135.18 | General |
| Category: Nephrology | ||||||
| 02/06/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.61 | General |
| Category: NEPHROLOGY | ||||||
| 01/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2022 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Sports Early Intervention | ||||||
| 12/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 09/29/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Rare Disease | ||||||
| 09/01/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 08/31/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Nephrology | ||||||
| 08/04/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Not Applicable | ||||||
| 04/08/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Hyperkalemia | ||||||
| 04/08/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Hyperkalemia | ||||||
| 03/29/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEPHROLOGY | ||||||
| 03/26/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,159 | 2,772 | $220,281 | $69,527 |
| 2022 | 32 | 1,886 | 4,100 | $358,619 | $124,919 |
| 2021 | 30 | 1,643 | 3,537 | $371,042 | $143,507 |
| 2020 | 33 | 2,108 | 4,844 | $452,219 | $181,688 |
Total Patients
6,796
Total Services
15,253
Medicare Billing
$519,640
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 105 | 179 | $55,631 | $19,117 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 86 | 124 | $28,095 | $8,284 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 105 | $15,912 | $6,301 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 47 | $13,380 | $4,863 | 36.3% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 21 | 730 | $20,433 | $4,427 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 59 | $12,486 | $4,032 | 32.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 38 | 50 | $10,949 | $2,663 | 24.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 42 | 64 | $7,926 | $2,589 | 32.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 22 | $4,579 | $1,946 | 42.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 46 | 65 | $5,772 | $1,886 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $6,023 | $1,716 | 28.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 63 | 141 | $4,467 | $1,459 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,867 | $1,383 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 148 | $2,220 | $1,243 | 56.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 63 | 137 | $6,850 | $1,043 | 15.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 24 | $2,304 | $903.60 | 39.2% |
| 80197 | Tacrolimus level | Office | 2023 | 22 | 63 | $2,595 | $847.98 | 32.7% |
| 83735 | Magnesium level | Office | 2023 | 58 | 121 | $2,432 | $794.97 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,329 | $748.33 | 32.1% |
| 84100 | Phosphate level | Office | 2023 | 60 | 124 | $1,763 | $576.60 | 32.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 57 | 113 | $3,390 | $574.04 | 16.9% |
| 84156 | Total protein level, urine | Office | 2023 | 57 | 113 | $1,244 | $406.80 | 32.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 16 | 30 | $1,227 | $400.80 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 37 | $1,531 | $382.32 | 25.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 56 | 118 | $1,122 | $366.98 | 32.7% |
About Dr. Scott Kendrick, MD
Dr. Scott Kendrick, MD is a Nephrology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104042365.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Kendrick, MD has received a total of $3,134 in payments from pharmaceutical and medical device companies, with $507.70 received in 2024. These payments were reported across 134 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,707).
As a Medicare-enrolled provider, Kendrick has provided services to 6,796 Medicare beneficiaries, totaling 15,253 services with total Medicare billing of $519,640. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Greenville, NC
- Active Since 04/17/2007
- Last Updated 12/20/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1104042365
Products in Payments
- Rayaldee (Drug) $342.22
- HA MINUTEMAN G3-R (Device) $299.16
- Parsabiv (Biological) $293.76
- FARXIGA (Drug) $158.20
- SAMSCA (Drug) $141.95
- LIBERTY SELECT CYCLER (Device) $135.18
- ReActiv8 (Device) $126.79
- GENERAL PAIN MANAGEMENT (Device) $124.17
- ACTHAR (Biological) $120.96
- Auryxia (Drug) $102.20
- Velphoro (Drug) $86.77
- BENLYSTA (Biological) $86.43
- NephroCheck Test (Device) $80.80
- Senza Spinal Cord Stimulation System (Device) $77.22
- RAYALDEE (Drug) $74.84
- LOKELMA (Drug) $61.38
- Veltassa (Drug) $59.41
- DIFICID (Drug) $59.23
- JYNARQUE (Drug) $57.37
- AURYXIA (Drug) $57.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Greenville
William Kendrick, M.d, M.D
Nephrology — Payments: $203,057
Nephrology $203,057
Dr. Barry Gorlitsky, Md, MD
Nephrology — Payments: $175,603
Nephrology $175,603
Blake Shusterman, Md, MD
Nephrology — Payments: $66,159
Nephrology $66,159
Richard Blair, M.d, M.D
Nephrology — Payments: $13,340
Nephrology $13,340
Anthony Provenzano
Nephrology — Payments: $10,873
Nephrology $10,873
Dr. Amita Patel, M.d, M.D
Nephrology — Payments: $9,091
Nephrology $9,091